Drug intelligence / Profile preview

Diurisa

Development stage
Discontinued
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Diurisa is a fixed-dose combination pharmaceutical drug containing furosemide (40 mg) and amiloride (10 mg). Furosemide is a loop diuretic that works by inhibiting the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle, leading to increased excretion of water, sodium, chloride, and potassium. Amiloride is a potassium-sparing diuretic that acts by blocking epithelial sodium channels (ENaC) in the distal tubule and collecting ducts, which reduces sodium reabsorption and helps to conserve potassium. This combination is used to treat edema (fluid retention) associated with conditions such as congestive heart failure, liver disease, and nephrotic syndrome, and also for hypertension. The amiloride component helps to mitigate the potassium loss often caused by furosemide alone.

Brand names
Diurisa
Other names
furosemide + amiloride hydrochloride
02

Targets

ENaC

Beyond the preview

Go deeper on Diurisa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diurisa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call